Jeffrey DiGiovanni - Feb 18, 2025 Form 4 Insider Report for INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC)

Signature
/s/ Jeffrey DiGiovanni
Stock symbol
ISSC
Transactions as of
Feb 18, 2025
Transactions value $
$0
Form type
4
Date filed
4/2/2025, 07:20 PM
Previous filing
Jun 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISSC Restricted Stock Units Award $0 +17.5K +26% $0.00 84.6K Feb 18, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISSC Non-Qualified Stock Option (Right to Buy) Award $0 +33.3K $0.00 33.3K Feb 18, 2025 Common Stock 33.3K $9.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSUs were granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. The number of RSUs is based on the methodology determined by the Company's compensation committee prior to the date of grant on February 18, 2025. The grant was confirmed by the Company's board of directors on April 1, 2025. Each RSU represents the right to receive one share of Common Stock, subject to adjustment as provided in the Award Agreement. The RSUs are scheduled to vest in accordance with the following schedule: 1/4th on the first anniversary of the grant date and 1/12th on each quarterly anniversary of the grant date thereafter, subject to continued employment by the reporting person.
F2 The non-qualified stock option was granted pursuant to the Company's 2019 Stock-Based Incentive Compensation Plan. The number of shares of Common Stock underlying the option is based on the methodology determined by the Company's compensation committee prior to the date of grant on February 18, 2025. The grant was confirmed by the Company's board of directors on April 1, 2025. The option is scheduled to vest in accordance with the following schedule: 1/4th on the first anniversary of the grant date and 1/12th on each quarterly anniversary of the grant date thereafter, subject to continued employment by the reporting person. The option becomes exercisable, if at all, if the price of the Company's common stock on the Nasdaq Stock Market is equal to or greater than $9.8785 for 20 consecutive trading days during the vesting period of the option.